Users of Ozempic and other drugs are shunning items like energy drinks and salty snacks, research shows. But there are ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effi ...
Investigational once-weekly retatrutide yielded the greatest weight loss of all GLP-1 receptor agonists, up to 22.1% after 48 ...
HealthDay News — For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published ...
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation. (HealthDay News) — For adults with overweight or obesity without ...
What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...